Ghrelin Resistance in Obesity: The Hunger Hormone Stops Working — Then Comes Back After Weight Loss
Diet-induced obese mice become resistant to ghrelin's appetite-stimulating effects, but losing weight restores ghrelin sensitivity — potentially explaining why hunger surges after dieting.
Quick Facts
What This Study Found
Mice made obese through a high-fat diet developed resistance to ghrelin — the hunger hormone stopped working properly. Specifically, obese mice had lower circulating ghrelin levels, lost the normal daily rhythm of ghrelin secretion, and no longer showed the typical ghrelin spike during fasting and refeeding. When given exogenous ghrelin injections, obese mice ate significantly less in response compared to lean mice.
Critically, when the obese mice lost weight, their sensitivity to ghrelin was restored. The authors suggest this means ghrelin inhibition after weight loss could potentially prevent weight regain — because ghrelin sensitivity returns precisely when it would drive overeating.
Key Numbers
C57BL/6J mice · Low-fat vs high-fat diet · Ghrelin levels reduced in obese mice · Diurnal ghrelin rhythm lost · Fasting ghrelin response abolished · Sensitivity restored with weight loss
How They Did This
Lean C57BL/6J mice were fed either chow, a low-fat diet, or a high-fat diet to induce obesity. Researchers measured plasma ghrelin levels, tracked daily ghrelin cycling patterns, tested fasting/refeeding ghrelin responses, and measured food intake after exogenous ghrelin administration in lean versus obese mice.
Why This Research Matters
Weight regain after dieting is the central challenge in obesity treatment. This study reveals a key mechanism: obesity blunts ghrelin signaling, but weight loss restores it. That restored ghrelin sensitivity could be one reason people feel ravenously hungry after losing weight — and why they regain it. Understanding this ghrelin rebound has directly influenced the development of anti-obesity strategies and helps explain why GLP-1 drugs that suppress appetite are so effective at maintaining weight loss.
The Bigger Picture
This 2004 study was among the first to demonstrate ghrelin resistance in obesity and, crucially, its reversal with weight loss. The concept of ghrelin rebound after dieting has become central to understanding why weight regain is so common. It also helps explain why GLP-1 receptor agonists — which powerfully suppress appetite through a different pathway — are so effective at maintaining weight loss where ghrelin-driven hunger would otherwise derail progress.
What This Study Doesn't Tell Us
Mouse study — ghrelin physiology differs somewhat between mice and humans. No specific ghrelin receptor or downstream signaling analysis was performed. The mechanism behind ghrelin resistance was not fully characterized. Weight loss intervention details are limited in the abstract.
Questions This Raises
- ?Could blocking ghrelin signaling after weight loss prevent the hunger rebound that leads to weight regain?
- ?Does the same ghrelin resistance-and-rebound pattern occur in humans who lose weight through diet versus bariatric surgery?
- ?What molecular mechanisms cause ghrelin receptor desensitization in obesity?
Trust & Context
- Key Stat:
- Ghrelin sensitivity restored after weight loss Obese mice couldn't respond to ghrelin's hunger signal, but losing weight brought sensitivity back — creating a perfect storm for rebound eating and weight regain.
- Evidence Grade:
- Rated low: animal study in mice using diet-induced obesity. While the findings are mechanistically informative and have been supported by subsequent human studies, direct clinical translation requires caution.
- Study Age:
- Published in 2004. This is a foundational paper in ghrelin resistance research. Its core findings have been confirmed and expanded by subsequent studies in both animals and humans.
- Original Title:
- Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss.
- Published In:
- International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 28(7), 879-85 (2004)
- Authors:
- Perreault, M, Istrate, N, Wang, L(2), Nichols, A J, Tozzo, E, Stricker-Krongrad, A
- Database ID:
- RPEP-00958
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is ghrelin resistance and why does it matter for weight loss?
Ghrelin resistance means your body stops responding normally to the hunger hormone. In obesity, ghrelin levels drop and the brain becomes less sensitive to its signals. But after weight loss, this sensitivity comes back — which may be why people feel much hungrier after losing weight, making regain more likely.
Could targeting ghrelin help prevent weight regain after dieting?
That's what the authors suggest. Since ghrelin sensitivity returns after weight loss, blocking ghrelin at that critical window could theoretically prevent the hunger surge that drives regain. This concept has influenced appetite-suppression research, though most current drugs target other pathways like GLP-1.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00958APA
Perreault, M; Istrate, N; Wang, L; Nichols, A J; Tozzo, E; Stricker-Krongrad, A. (2004). Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss.. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 28(7), 879-85.
MLA
Perreault, M, et al. "Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss.." International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2004.
RethinkPeptides
RethinkPeptides Research Database. "Resistance to the orexigenic effect of ghrelin in dietary-in..." RPEP-00958. Retrieved from https://rethinkpeptides.com/research/perreault-2004-resistance-to-the-orexigenic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.